The global liquid biopsy market has emerged as one of the most promising segments in molecular diagnostics, driven by advancements in precision medicine and oncology. Valued at USD 11.91 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 11.9% between 2025 and 2034, reaching USD 36.59 billion by 2034. Liquid biopsy, a...